The Chromatin Remodeling Gene, ARID1A, Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Wala, S. J.
Lichner, Z.
Scorilas, A.
White, N. M. A.
Girgis, A. H.
Rotstein, L.
Wiegand, K. C.
Latif, A.
Chow, C.
Huntsman, D.
Yousef, G. M.
机构：
[1] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Athens, Athens, Greece
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[5] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[6] GPEC, Vancouver, BC, Canada
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1063
引用
收藏
页码：255A / 255A
页数：1
相关论文
共 50 条
  • [21] Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Chen, Shao-An
    Zhang, Jun-Peng
    Wang, Ning
    Chen, Ji
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [22] Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
    Girgis, Hala
    Masui, Olena
    White, Nicole M. A.
    Scorilas, Andreas
    Rotondo, Fabio
    Seivwright, Annetta
    Gabril, Manal
    Filter, Emily R.
    Girgis, Andrew H. A.
    Bjarnason, Georg A.
    Jewett, Michael A. S.
    Evans, Andrew
    Al-Haddad, Sahar
    Siu, K. W. Michael
    Yousef, George M.
    MOLECULAR CANCER, 2014, 13
  • [23] Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Chen, Shao-An
    Zhang, Jun-Peng
    Wang, Ning
    Chen, Ji
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [24] MiR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Ibrahim, Rania
    Samaan, Sara
    Khella, Heba
    Ding, Qiang
    Evans, Andrew
    Lianidou, Evi
    Gabril, Manal
    Krylov, Sergey
    Jewett, Michael
    Bjarnason, Georg
    Yousef, George
    MODERN PATHOLOGY, 2015, 28 : 231A - 231A
  • [25] Prognostic value of a gene signature in clear cell renal cell carcinoma
    Chen, Liang
    Luo, Yongwen
    Wang, Gang
    Qian, Kaiyu
    Qian, Guofeng
    Wu, Chin-Lee
    Dan, Han C.
    Wang, Xinghuan
    Xiao, Yu
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 10324 - 10335
  • [26] Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, Daichi
    Mao, Tsui-Lien
    Fukayama, Masashi
    Nakagawa, Shunsuke
    Yano, Tetsu
    Taketani, Yuji
    Shih, Ie-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (12): : 5121 - 5129
  • [27] Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma.
    Maeda, D.
    Mao, T-L
    Fukayama, M.
    Wang, T-L
    Shih, I-M
    LABORATORY INVESTIGATION, 2011, 91 : 259A - 259A
  • [28] ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
    Caumanns, Joseph J.
    Wisman, G. Bea A.
    Berns, Katrien
    van der Zee, Ate G. J.
    de Jong, Steven
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 176 - 184
  • [29] Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
    Choi, Jae Yoon
    Han, Hyun Ho
    Kim, Young Tae
    Lee, Joo Hyun
    Kim, Baek Gil
    Kang, Suki
    Cho, Nam Hoon
    YONSEI MEDICAL JOURNAL, 2017, 58 (01) : 59 - 66
  • [30] Higher Expression of CDKN2A Gene Is Potential Prognostic Marker for Clear Cell Renal Cell Carcinoma
    Tawedrous, Eriny
    Wala, Samantha J.
    Saleeb, Rola
    Rotondo, Fabio
    Ding, Qiang
    Yousef, George M.
    LABORATORY INVESTIGATION, 2016, 96 : 266A - 266A
12345